Stories
Stocks to Watch: HDFC Bank, ICICI Pru, Bajaj Fin, DMart, Canara Bank & More on Oct 5
C
CNBC TV18•04-10-2026, 12:21
Stocks to Watch: HDFC Bank, ICICI Pru, Bajaj Fin, DMart, Canara Bank & More on Oct 5
- •HDFC Bank appoints Anup Bagchi as MD & CEO for a three-year term, approved by RBI.
- •Infosys and Wipro ADRs jump 8% after Accenture's strong Q4 results and upbeat outlook.
- •UCO Bank reports 18.84% YoY growth in total business, driven by a 24.68% rise in advances.
- •Aurobindo Pharma receives USFDA approval to market Perampanel tablets in multiple strengths.
- •Hindustan Zinc's mined metal production rises 5% YoY to 271 kilotonnes; saleable metal production up 7% YoY.
- •ICICI Prudential Life Insurance appoints Siddhartha Mishra as MD & CEO for a five-year term.
- •Bharat Coking Coal sees 20.7% YoY increase in total raw coal production to 2.57 million tonnes.
- •SRF Ltd receives show cause notice for alleged disallowance of input tax credit totaling ’266.32 crore.
- •RVNL's LOA for an IP-based video surveillance system from East Coast Railway is cancelled by mutual consent.
- •Muthoot Finance appoints Alexander George as MD and George Alexander Muthoot as Vice Chairman and Whole-Time Director.
- •PNB receives administrative warning from SEBI over alleged insider trading rule violations.
- •Indian Bank's total business rises 14.2% YoY and 4.4% sequentially to ’15.96 lakh crore.
- •MOIL raises manganese ore prices by 5% across all grades for October 2026.
- •IREDA's additional charge of CMD for Dr. Bijay Kumar Mohanty is extended for three months.
- •Bajaj Finance board approves preferential issue of warrants up to ’5,800 crore.
- •Bank of Baroda's global business grows 17.45% YoY to ’32.64 lakh crore as of September 30, 2026.
- •IDBI Bank reports 18% YoY growth in total business to ’6.27 lakh crore in Q2.
- •Canara Bank's domestic advances rise 16.8% YoY to ’12.63 lakh crore; global business up 15.8%.
Key Questions Answered
Anup Bagchi has been appointed as the new Managing Director and CEO of HDFC Bank for a three-year term following approval from the Reserve Bank of India.
Siddhartha Mishra was appointed as the next Managing Director and Chief Executive Officer of ICICI Prudential Life Insurance for a five-year term, succeeding Anup Bagchi.
Aurobindo Pharma Limited received final approval from the US Food and Drug Administration to manufacture and market Perampanel tablets in strengths ranging from 2 mg to 12 mg.
